News & Events 2020

CTI Clinical Trial and Consulting Services Announces Acquisition of Middle East/Northern African based Clinart

September 16, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ September 16, 2020] – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization announces the acquisition of Clinart, a full-service contract research organization, with nearly 20 years of experience ...

Read More

August New Hires & Promotions

August 31, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Joanna Brown joins as Clinical Research Associate II Carmen Cespedes Cevasco joins as Senior Clinical Research Associate Emily Crawford joins as Senior Clinical Research Associate Barbara McCarty ...

Read More

Consistent Quality Regulation Allows for Multiple COVID-19 Related EUAs

August 31, 2020

As we enter into the ninth month of the COVID-19 pandemic, new SARS-Cov-2 infections continue to occur, both at home in the United States and abroad. World leaders, global health organizations, national and state ...

Read More

CTI and Hepion Pharmaceuticals Announces First NASH Patient Dosed with CRV431 in Phase 2 Clinical Trial

August 13, 2020

FOR IMMEDIATE RELEASE [Covington, KY] August 13, 2020 – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, and Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a biopharmaceutical company focusing on the development of therapeutic drugs for the treatment ...

Read More

CTI and Arcturus Therapeutics Announce Initiation of Dosing of COVID-19 Vaccine Candidate, LUNAR-COV19 (ARCT-021) in a Phase 1/2 Study

August 11, 2020

Potential for highly differentiated COVID-19 vaccine profile with a single administration, at a low dose Clinical study data expected in Q4 2020 FOR IMMEDIATE RELEASE [San Diego, CA and Covington, KY, August 11, 2020] –Arcturus Therapeutics Holdings Inc. (the “Company”, ...

Read More

CTI and Humanigen Expand Phase III Study of Lenzilumab in COVID-19 to Brazil

August 10, 2020

FOR IMMEDIATE RELEASE [Burlingame, CA and Covington, KY, August 10, 2020 ]– Humanigen, Inc., (HGEN) (“Humanigen”), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company’s proprietary Humaneered® anti-human granulocyte macrophage-colony stimulating factor (GM-CSF) monoclonal antibody, ...

Read More

Angion Enrolls First Patients in Phase 2 Clinical Trial of ANG-3777 in Patients with Acute Lung Injury Associated with COVID-19 Pneumonia

August 4, 2020

FOR IMMEDIATE RELEASE [San Francisco, CA and Covington, KY, August 4, 2020 ] – Angion Biomedica Corp. (Angion), a late-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel small molecule therapeutics to address acute organ injuries and fibrotic diseases, ...

Read More

July New Hires & Promotions

July 31, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Megan Christopher joins as Research Associate Olivia Frederick joins as Research Associate Joe Gurevicius joins as Research Associate Yolanda Hill promoted to Senior Recruiter, Pathient Recruitement Lynn ...

Read More

Maintaining Quality Services by Committing to Exceptional Training

July 31, 2020

Flexibility, agility, and the ability to respond to the unknown are virtues that become increasingly essential in the world of clinical trials. Companies can struggle to equip their employees with the necessary tools to ...

Read More

CTI Manager, Clinical Project Coordination Honored at Next Generation Leadership Awards

July 17, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ July 17, 2020] CTI Clinical Trial & Consulting (CTI), a multi-national, privately held, full-service contract research organization is proud to announce the recognition of Jamie Hilfer, CTI Manager of Clinical Project Coordination, at the Northern Kentucky ...

Read More

Medidata Partners with CTI for Remote Source Review of Clinical Trials in Response to COVID-19

July 8, 2020

FOR IMMEDIATE RELEASE [Covington, KY and New York, NY ~ July 9, 2020] – Medidata, the global leader in creating end-to-end solutions to support the entire clinical trial process, and a Dassault Systèmes company, announced that CTI Clinical Trial and Consulting Services, ...

Read More

New Hires & Promotions

June 30, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Lindy Bush joins as Clinical Data Associate II Kateline Piedade joins as Clinical Data Manager I Lindsey VanFleet joins as Clinical Data Manager II

Read More

Global Research Must Continue in Areas Other Than COVID-19 to Advance Treatments

June 30, 2020

The global COVID-19 pandemic has affected all of us. It has changed the way many companies do business, and it has impacted how clinical research is conducted. At CTI, we, like so many other ...

Read More

CTI Named #1 CRO in the World for Quality at 2020 CRO Leadership Awards

June 25, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ June 25, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO) was named Champion in multiple categories of the 2020 CRO Leadership Awards, and was the only CRO ...

Read More

CTI Announces Data Management Team Expansion and Legal Affairs Team Promotion

June 19, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ June 19, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO) is pleased to announce the addition of Sandra Miller to the Data Management ...

Read More

Media Coverage of CTI's COVID-19 Work

June 4, 2020

CTI - One of Founding Contributers of NKY Coronavirus Emergency Relief Fund CTI is proud to be one of othe original contributers to a local relief fund for those affected by the pandemic. Coverage by the NKY Tribune Coverage by The Lane Report Coverage by the Cincinnati Enquirer Coverage ...

Read More

New Hires & Promotions

May 29, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Zhanna Andrushchenko joins as Senior Statistical Programmer Daniela Carvalho moves to new role as Clinical Data Associate II Evelyn Currie joins as Senior Clinical Data Associate Dana ...

Read More

Recognizing the Regulatory Agencies Supporting the Fight Against COVID-19

May 28, 2020

The COVID-19 pandemic has spotlighted the courageous work of health care workers, first responders, delivery people, grocery store clerks and stockers, and others in the supply chain providing care, food, and medical supplies ...

Read More

Recognizing the Regulatory Agencies Supporting the Fight Against COVID-19

May 28, 2020

The COVID-19 pandemic has spotlighted the courageous work of health care workers, first responders, delivery people, grocery store clerks and stockers, and others in the supply chain providing care, food, and medical supplies ...

Read More

CTI Announces Anna McBride to Oversee Global Clinical Monitoring Department

May 27, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ May 27, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization announces the addition of Anna McBride to the CTI team in the role of Vice President, Global Clinical ...

Read More

CTI Partners with St. Elizabeth Healthcare and Pulmotect to Open First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19

May 18, 2020

FOR IMMEDIATE RELEASE [Covington, KY / Edgewood, KY ~ May 18, 2020] – St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc., in partnership with CTI ...

Read More

CTI Partners with St. Elizabeth Healthcare and Pulmotect to Open First Hospital Site for Phase-2 Clinical Trial Targeting COVID-19

May 18, 2020

FOR IMMEDIATE RELEASE [Covington, KY / Edgewood, KY ~ May 18, 2020] – St. Elizabeth Healthcare has been selected as the first site of the FDA-approved Phase-2 COVID-19 clinical trial studying the drug PUL-042 of Pulmotect, Inc., in partnership with CTI ...

Read More

CTI Partners with Pulmotect on Two Phase-2 Trials Targeting COVID-19

May 11, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ May 11, 2020] – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, is partnering with Pulmotect, Inc., a clinical-stage biotechnology company, on two COVID-19 phase 2 clinical trials ...

Read More

CTI Partners with Pulmotect on Two Phase-2 Trials Targeting COVID-19

May 11, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ May 11, 2020] – CTI Clinical Trial and Consulting Services (CTI), a global, privately held, full-service contract research organization, is partnering with Pulmotect, Inc., a clinical-stage biotechnology company, on two COVID-19 phase 2 clinical trials ...

Read More

First Patient Dosed in FDA-Approved Phase III Lenzilumab Study for COVID-19

May 7, 2020

First Phase III pivotal study for an anti-GM-CSF therapy in COVID-19 patients First patient dosed in US randomized, double-blind, placebo-controlled, multi-center, Phase III study with an anti-GM-CSF monoclonal antibody which, if successful, may lead to lenzilumab product ...

Read More

First Patient Dosed in FDA-Approved Phase III Lenzilumab Study for COVID-19

May 7, 2020

First Phase III pivotal study for an anti-GM-CSF therapy in COVID-19 patients First patient dosed in US randomized, double-blind, placebo-controlled, multi-center, Phase III study with an anti-GM-CSF monoclonal antibody which, if successful, may lead to lenzilumab product ...

Read More

New Hires & Promotions

April 30, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Mariah Dooley promoted to Clinical Data Manager I Gerrit Hobson promoted to Research Scientist I, Regulatory & Scientific Affairs Sofia Jesus moves to new role as Regulatory ...

Read More

CTI Clinical Research Center - A COVID-19 Vaccine Site

April 30, 2020

Over the past several weeks, the CTI Clinical Research Center (CRC) has been proactively preparing to support upcoming COVID-19 vaccine trials. With three decades of research experience and over 1,000 trials completed, the CTI ...

Read More

CTI Clinical Research Center - A COVID-19 Vaccine Site

April 30, 2020

Over the past several weeks, the CTI Clinical Research Center (CRC) has been proactively preparing to support upcoming COVID-19 vaccine trials. With three decades of research experience and over 1,000 trials completed, the CTI ...

Read More

FDA Approves Initiation of Phase III Study of Lenzilumab in COVID-19 patients

April 15, 2020

Company intends to begin enrolling patients as soon as possible at several leading centers Phase III study enrollment to focus on adult, hospitalized patients with COVID-19 penumonia and at high risk of progression to respiratory failure ...

Read More

FDA Approves Initiation of Phase III Study of Lenzilumab in COVID-19 patients

April 15, 2020

Company intends to begin enrolling patients as soon as possible at several leading centers Phase III study enrollment to focus on adult, hospitalized patients with COVID-19 penumonia and at high risk of progression to respiratory failure ...

Read More

CTI Partners with Humanigen for Planned Phase III Study for Lenzilumab for Coronavirus Treatment

March 30, 2020

Study to tackle leading cause of death in COVID-19 patients Lenzilumab, a monoclonal antibody that neutralizes granulocyte macrophage colony stimulating factor (GM-CSF) GM-CSF is up-regulated in COVID-19 patients and may cause a harmful immune response leading to ...

Read More

CTI Partners with Humanigen for Planned Phase III Study for Lenzilumab for Coronavirus Treatment

March 30, 2020

Study to tackle leading cause of death in COVID-19 patients Lenzilumab, a monoclonal antibody that neutralizes granulocyte macrophage colony stimulating factor (GM-CSF) GM-CSF is up-regulated in COVID-19 patients and may cause a harmful immune response leading to ...

Read More

How CTI Can Help Fight the Impact of COVID-19

March 27, 2020

What CTI Can Do to Help Fight the Impact of COVID-19 CTI is dedicated to helping our partners, team members, and communities work through the COVID-19 pandemic. Whether that means helping adjust programs impacted ...

Read More

How CTI Can Help Fight the Impact of COVID-19

March 27, 2020

What CTI Can Do to Help Fight the Impact of COVID-19 CTI is dedicated to helping our partners, team members, and communities work through the COVID-19 pandemic. Whether that means helping adjust programs impacted ...

Read More

New Hires & Promotions

March 26, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Tolu Agbede promoted to Clinical Research Associate I Christiane Bradaczek joins as Senior Clinical Research Associate Dario Corrari joins as Senior Clinical Research Associate Nick DelBuono joins ...

Read More

CTI Announces Promotions in the Training and Information Technology Departments

March 12, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ March 12, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization (CRO) ...

Read More

CTI Medical Director to Lead Tri-State American Society of Hematology Update

March 6, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ March 6, 2020] Dr. Elias Anaissie, Medical Director at CTI Clinical Trial and Consulting (CTI), a global, privately held, full-service contract research organization, will be directing the Tri-State American Society of Hematology (ASH) Update on Saturday, March 7 in Cincinnati, OH. The annual ...

Read More

Rare Disease Day 2020

February 28, 2020

Each year on the last day of February, the rare disease community comes together to raise awareness for ...

Read More

February New Hires & Promotions

February 27, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Kenneth Ball joins as Clinical Research Associate I Anthony Bucaro promoted to Contract Specialist I Hadley Decker promoted to Director, Global Training and ...

Read More

CTI Announces Promotions in the Real World Evidence & Late Phase and Clinical Trials Departments

February 12, 2020

CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is pleased to announce the promotions of Ana Patacão to Executive ...

Read More

CTI Announces Additions to the Business Development and Regulatory & Scientific Affairs Teams

February 4, 2020

FOR IMMEDIATE RELEASE [Covington, KY ~ February 4, 2020] CTI Clinical Trial and Consulting Services (CTI), a multi-national, privately held, full-service contract research organization is ...

Read More

January New Hires & Promotions

January 31, 2020

CTI welcomes all the new employees who have recently joined the team, and congratulates the employees who have recently received a promotion! Maria João Almeida promoted to Clinical Research Associate I Khaled Alsaleh joins as Clinical Research Associate II Luke Bernahrdt promoted to Senior Clinical ...

Read More

Real-World Evidence: Taking Stock of 2019 and Expanding into 2020

January 31, 2020

As the CTI global Real-World Evidence and Late Phase Research team begins the year 2020 and the new ...

Read More

Subscribe to our mailing list

* indicates required